Clinical Trial on Ayurvedic Tablet Kanyalohadi Vati foR Primary Dysmenorrhea

EVALUATION OF EFFICACY OF KANYALOHADI VATI IN UDAVARTINI YONIVYAPATH VIS A VIS TO PRIMARY DYSMENORRHOEA -AN OPEN LABEL SINGLE ARM CLINICAL STUDY - no

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058399

Enrollment

Registered

2023-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Age group 16-32 years -patient with regular cycles complaining of painful menstruation for at least three consecutive cycles

Exclusion criteria

Exclusion criteria: -Pelvic pathology – Known case of Fibroid, Adenomyosis, Endometriosis, PID, Menorrhagia, Malignancy. -Patients with intrauterine contraceptive devices or on contraceptive pills. -Congenital anomalies of reproductive system. -Metabolic disorders – known case of Diabeties Mellitus , Hypertension , Thyroid dysfunction.

Design outcomes

Primary

Measure	Time frame
this study is done for symptomatic management of pain in primary dysmenorrhea with ayurvedic tablet kanyalohadi vatiTimepoint: 30 Days	—

Secondary

Measure	Time frame
Symptomatic Relief In The SymptomsTimepoint: 90 Days;this medicine will help to get rid of painful menses experience , & will not lead to effect the day to day activityTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr. Sonal Singh

JSS Ayurveda Medical College

seemantinij@gmail.com7349496230

Outcome results